Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for GlycoMimetics, Inc. (GLYC)

« Back to company index

GLYC Chatter Timeline

Stock Ticker for GLYC

Most Active Tweeters for GLYC

UserTweets
@gcassidy718 3
@BlueBioNow 3
@Estimize 3
@StockNewsNow 2
@newsfilterio 2

Recent Tweets for GLYC

StockNewsNow @StockNewsNow
$GLYC GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2019 https://t.co/OtonfxwUI3
February 28th 2020, 12:02pm
newsfilterio @newsfilterio
GlycoMimetics EPS beats by $0.01 $GLYC https://t.co/jk57HTFXAH
February 28th 2020, 11:02am
AlertTrade @AlertTrade
UP WITH EARNINGS TODAY ALERT: $GLYC GlycoMimetics, Inc ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room
February 28th 2020, 10:02am
Stock_News_Now @Stock_News_Now
$GLYC: New SEC Filing for GLYC: Form 10-K (No. 0001558370-20-001723): https://t.co/fuANdVDoIF
February 28th 2020, 8:02am
Estimize @Estimize
Well done Roth_30 beating 8 other analysts to take the win for $GLYC - https://t.co/cqdqNmhxOf
February 28th 2020, 8:02am
Estimize @Estimize
$GLYC beats the Estimize EPS Consensus by 1c and misses the Estimize Revenue Consensus by $0.01M. Reports FQ4 earni… https://t.co/YOzgQ1MkL1
February 28th 2020, 8:02am
Estimize @Estimize
$GLYC reports FQ4 earnings of -34c EPS and $0M Revs - https://t.co/qGyjtpWOUG
February 28th 2020, 8:02am
MarketCurrents @MarketCurrents
$GLYC - GlycoMimetics EPS beats by $0.01 https://t.co/PJbBGFVRsq
February 28th 2020, 8:02am
otcdynamics @otcdynamics
$GLYC GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2019 https://t.co/1Ac7SM06F9
February 28th 2020, 8:02am
newsfilterio @newsfilterio
GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2019 $GLYC https://t.co/VImyXSTGf3
February 28th 2020, 8:02am
BlueBioNow @BlueBioNow
$GLYC considerable price movement -3.14 % change recently https://t.co/XgwQoI5WeD
February 27th 2020, 10:02pm
1stOncology @1stOncology
#GlycoMimetics to Present at the Cowen and Company 40th Annual #HealthCareConference 2020 $GLYC https://t.co/aP9fqJ9vYV
February 26th 2020, 5:02am
gcassidy718 @gcassidy718
$GLYC Hurting with one -3.02 % change recently https://t.co/OpTFVD2XBu
February 25th 2020, 5:02pm
StockNewsNow @StockNewsNow
$GLYC GlycoMimetics to Present at the Cowen and Company 40th Annual Health Care Conference 2020 https://t.co/y1prsUPAUT
February 25th 2020, 5:02pm
gcassidy718 @gcassidy718
$GLYC Valuation is starting to make more sense now $3.59. https://t.co/OpTFVD2XBu
February 24th 2020, 2:02pm
BlueBioNow @BlueBioNow
$GLYC I'd like to make an exit, just not now -2.61 % change recently https://t.co/XgwQoI5WeD
February 23rd 2020, 6:02pm
dispatchtribune @dispatchtribune
GlycoMimetics Inc $GLYC Receives $9.25 Average PT from Analysts https://t.co/n84cvLcgki
February 23rd 2020, 12:02pm
dakotafinancial @dakotafinancial
GlycoMimetics Inc $GLYC Receives $9.25 Average PT from Analysts https://t.co/p936L5ouRP
February 23rd 2020, 12:02pm
BlueBioNow @BlueBioNow
$GLYC waiting for the turn around . . . -2.61 % change recently https://t.co/XgwQoI5WeD
February 22nd 2020, 6:02pm
WeekHerald @WeekHerald
Analysts Set GlycoMimetics Inc $GLYC Target Price at $9.25 https://t.co/ph1g04AjBA
February 21st 2020, 10:02am
OlympiaReport @OlympiaReport
GlycoMimetics Inc $GLYC Given Average Rating of “Buy” by Brokerages https://t.co/7JIsyzKdnw
February 21st 2020, 10:02am
gcassidy718 @gcassidy718
$GLYC was oversold imo -2.08 % https://t.co/OpTFVD2XBu
February 19th 2020, 11:02am
IBD_AGatlin @IBD_AGatlin
@icer_review $GLYC and $OVID are also developing orphan drugs, though they haven't gained those approvals yet.
February 19th 2020, 10:02am
TheMarketsDaily @TheMarketsDaily
GlycoMimetics Inc $GLYC Receives $9.25 Consensus Price Target from Brokerages https://t.co/YxgOn7jby4
February 19th 2020, 6:02am
bbnsnews @bbnsnews
GlycoMimetics Inc $GLYC Receives $9.25 Average PT from Brokerages https://t.co/0aGG3eYtby
February 19th 2020, 6:02am
sxhalt @sxhalt
sold 500 shares $GLYC 4.28. (that 4.50 tp was not meant for today and I'll look to rebuy tomorrow if it pulls back at the open)
February 18th 2020, 3:02pm
sxhalt @sxhalt
bougt 700 shares $GLYC @ 4.06. clear support at 4, looking for reversal in 90 day downtrend. tp 4.50
February 18th 2020, 11:02am
ThisLincolnian @ThisLincolnian
-$0.35 EPS Expected for GlycoMimetics Inc $GLYC This Quarter https://t.co/aAQ4YKgpVQ
February 17th 2020, 1:02pm
AmericanBanking @AmericanBanking
GlycoMimetics Inc $GLYC Receives Average Recommendation of “Buy” from Brokerages https://t.co/XdMyUqxusw #stocks
February 16th 2020, 5:02pm
dailypoliticaln @dailypoliticaln
GlycoMimetics Inc $GLYC Receives Average Rating of “Buy” from Analysts https://t.co/Dv1OTNnYZV
February 16th 2020, 5:02pm
TranscriptDaily @TranscriptDaily
Zacks: Analysts Expect GlycoMimetics Inc $GLYC Will Announce Earnings of -$0.35 Per Share https://t.co/SMZcV39cc6
February 15th 2020, 9:02am
Stock_News_Now @Stock_News_Now
$GLYC: New SEC Filing for GLYC: Form SC 13G/A (No. 0000921895-20-000539): https://t.co/nXSNWLRz7g
February 14th 2020, 3:02pm
HealthcareBeat @HealthcareBeat
Form SC 13G/A (statement of acquisition of beneficial ownership by individuals) filed with the SEC $GLYC https://t.co/1PQobHANah
February 14th 2020, 3:02pm
gcassidy718 @gcassidy718
$GLYC significant stock price movement -2.40 % change recently https://t.co/OpTFVD2XBu
February 13th 2020, 12:02pm
WeekHerald @WeekHerald
Zacks: Brokerages Expect GlycoMimetics Inc $GLYC to Announce -$0.35 EPS https://t.co/O4ICmXYBFn
February 12th 2020, 3:02pm
AmericanBanking @AmericanBanking
-$0.35 EPS Expected for GlycoMimetics Inc $GLYC This Quarter https://t.co/8PGFn8CJxW #stocks
February 12th 2020, 3:02pm
OlympiaReport @OlympiaReport
-$0.35 EPS Expected for GlycoMimetics Inc $GLYC This Quarter https://t.co/j2JuElvPcr
February 12th 2020, 3:02pm
endpts @endpts
Pfizer uncouples from GlycoMimetics and its failed sickle cell disease drug https://t.co/CDRQDG3ueb $PFE $GLYC
February 11th 2020, 11:02pm
pjl001 @pjl001
Pfizer axes license agreement with GlycoMimetics https://t.co/HjSK7F5Eh0 $PFE, $GLYC Great Dividend Stock BUY PFE!
February 11th 2020, 4:02pm
felipepotes83 @felipepotes83
Pfizer $PFE axes license agreement with GlycoMimetics $GLYC https://t.co/i9cvSF6eBx
February 11th 2020, 2:02pm
StckPro @StckPro
$PFE $GLYC NEW ARTICLE : Pfizer axes license agreement with GlycoMimetics https://t.co/fdcHghFyPY Get all the lates… https://t.co/wxhda6fhV0
February 11th 2020, 1:02pm
MarketCurrents @MarketCurrents
$PFE $GLYC - Pfizer axes license agreement with GlycoMimetics https://t.co/OupcLFeYgL
February 11th 2020, 1:02pm
christymaginn @christymaginn
RT @jeff_cranmer: $PFE terminates rivipansel deal with $GLYC three months after failed pan-selectin antagonist failed in sickle cell https:…
February 10th 2020, 4:02pm
jeff_cranmer @jeff_cranmer
$PFE terminates rivipansel deal with $GLYC three months after failed pan-selectin antagonist failed in sickle cell… https://t.co/pQQcH9wta7
February 10th 2020, 4:02pm
Stock_News_Now @Stock_News_Now
$GLYC: New SEC Filing for GLYC: Form 8-K (No. 0001558370-20-000636): https://t.co/Y71PVJ9jjr
February 10th 2020, 4:02pm
Gambiste1 @Gambiste1
RT @HealthcareBeat: Form SC 13G/A (statement of acquisition of beneficial ownership by individuals) filed with the SEC $GLYC https://t.co/F…
February 9th 2020, 7:02am
HealthcareBeat @HealthcareBeat
Form SC 13G/A (statement of acquisition of beneficial ownership by individuals) filed with the SEC $GLYC https://t.co/FZeUTfvvsq
February 9th 2020, 6:02am
WatchlistN @WatchlistN
GlycoMimetics $GLYC Shares Cross Below 50-Day Moving Average of $4.98 https://t.co/dU8EC1zjJX
February 8th 2020, 10:02am
ConsumerFeed @ConsumerFeed
GlycoMimetics $GLYC Shares Pass Below Fifty Day Moving Average of $4.98 https://t.co/avB2qJMbbB
February 8th 2020, 10:02am
newsfilterio @newsfilterio
Form SC 13G/A (statement of acquisition of beneficial ownership by individuals) filed with the SEC $GLYC https://t.co/bBY3zaGQEq
February 8th 2020, 5:02am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.